BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 27755242)

  • 1. Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: cardiovascular magnetic resonance and nuclear cardiology.
    Pepe A; Pizzino F; Gargiulo P; Perrone-Filardi P; Cadeddu C; Mele D; Monte I; Novo G; Zito C; Di Bella G
    J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1 Special issue on Cardiotoxicity from Antiblastic Drugs and Cardioprotection():e45-e54. PubMed ID: 27755242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: cardiovascular magnetic resonance and nuclear cardiology.
    Pepe A; Pizzino F; Gargiulo P; Perrone-Filardi P; Cadeddu C; Mele D; Monte I; Novo G; Zito C; Di Bella G
    J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1():S45-54. PubMed ID: 27183525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: role of echocardiography.
    Zito C; Longobardo L; Cadeddu C; Monte I; Novo G; Dell'Oglio S; Pepe A; Madonna R; Tocchetti CG; Mele D
    J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1 Special issue on Cardiotoxicity from Antiblastic Drugs and Cardioprotection():e35-e44. PubMed ID: 27755241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: role of echocardiography.
    Zito C; Longobardo L; Cadeddu C; Monte I; Novo G; Dell'Oglio S; Pepe A; Madonna R; Tocchetti CG; Mele D
    J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1():S35-44. PubMed ID: 27183524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy-induced cardiotoxicity: new insights into mechanisms, monitoring, and prevention.
    Cadeddu Dessalvi C; Deidda M; Mele D; Bassareo PP; Esposito R; Santoro C; Lembo M; Galderisi M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):315-323. PubMed ID: 29708912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on cardiotoxicity of anti-cancer treatments.
    Rosa GM; Gigli L; Tagliasacchi MI; Di Iorio C; Carbone F; Nencioni A; Montecucco F; Brunelli C
    Eur J Clin Invest; 2016 Mar; 46(3):264-84. PubMed ID: 26728634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recommended practical approach to the management of target therapy and angiogenesis inhibitors cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology.
    Maurea N; Spallarossa P; Cadeddu C; Madonna R; Mele D; Monte I; Novo G; Pagliaro P; Pepe A; Tocchetti CG; Zito C; Mercuro G
    J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1 Special issue on Cardiotoxicity from Antiblastic Drugs and Cardioprotection():e93-e104. PubMed ID: 27755247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced imaging modalities to detect cardiotoxicity.
    Awadalla M; Hassan MZO; Alvi RM; Neilan TG
    Curr Probl Cancer; 2018 Jul; 42(4):386-396. PubMed ID: 30297038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Echocardiography and Alternative Cardiac Imaging Strategies for Long-Term Cardiotoxicity Surveillance of Cancer Survivors Treated with Chemotherapy and/or Radiation Exposure.
    Garg V; Vorobiof G
    Curr Oncol Rep; 2016 Aug; 18(8):52. PubMed ID: 27461436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardio-oncology Part II: the monitoring, prevention, detection and treatment of chemotherapeutic cardiac toxicity.
    O'Hare M; Murphy K; Mookadam F; Sharma A; Lee H
    Expert Rev Cardiovasc Ther; 2015 May; 13(5):519-27. PubMed ID: 25864865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tales from the future-nuclear cardio-oncology, from prediction to diagnosis and monitoring.
    Mikail N; Chequer R; Imperiale A; Meisel A; Bengs S; Portmann A; Gimelli A; Buechel RR; Gebhard C; Rossi A
    Eur Heart J Cardiovasc Imaging; 2023 Aug; 24(9):1129-1145. PubMed ID: 37467476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiblastic drug-induced cardiotoxicity and cardioprotection: a compendium.
    Mercuro G
    J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1 Special issue on Cardiotoxicity from Antiblastic Drugs and Cardioprotection():e1-e2. PubMed ID: 27755236
    [No Abstract]   [Full Text] [Related]  

  • 13. The Role of Cardiovascular Magnetic Resonance for Surveillance of Cardiac Performance upon Receipt of Potentially Cardiotoxic Cancer Therapeutics.
    Parashar A; Hundley WG
    Curr Cardiol Rep; 2018 Oct; 20(12):142. PubMed ID: 30367282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear Imaging for the Assessment of Cardiotoxicity from Chemotherapeutic Agents in Oncologic Disease.
    Sreenivasan J; Hooda U; Ranjan P; Jain D
    Curr Cardiol Rep; 2021 May; 23(6):65. PubMed ID: 33961140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced Imaging Modalities to Monitor for Cardiotoxicity.
    Seraphim A; Westwood M; Bhuva AN; Crake T; Moon JC; Menezes LJ; Lloyd G; Ghosh AK; Slater S; Oakervee H; Manisty CH
    Curr Treat Options Oncol; 2019 Aug; 20(9):73. PubMed ID: 31396720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac imaging in cardiotoxicity: a focus on clinical practice.
    Makavos G; Ikonomidis I; Palios J; Rigopoulos A; Katogiannis K; Parissis J; Paraskevaidis I; Noutsias M
    Heart Fail Rev; 2021 Sep; 26(5):1175-1187. PubMed ID: 32306221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiotoxicity Associated with Chemotherapy Used in Gastrointestinal Tumours.
    Radulescu LM; Radulescu D; Ciuleanu TE; Crisan D; Buzdugan E; Romitan DM; Buzoianu AD
    Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer therapy-induced cardiotoxicity: role of ultrasound deformation imaging as an aid to early diagnosis.
    Mele D; Rizzo P; Pollina AV; Fiorencis A; Ferrari R
    Ultrasound Med Biol; 2015 Mar; 41(3):627-43. PubMed ID: 25619777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for early detection of cardiotoxicities from anticancer therapy in adults: evolving imaging techniques and emerging serum biomarkers.
    Akhter N; Murtagh G; Yancy C
    Future Oncol; 2015; 11(14):2093-103. PubMed ID: 26198839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of echocardiography in the detection and the monitoring of left ventricular systolic dysfunction in patients undergoing cancer therapy].
    Charbonnel C
    Ann Cardiol Angeiol (Paris); 2020 Nov; 69(5):255-261. PubMed ID: 32962803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.